Provided by Tiger Trade Technology Pte. Ltd.

NovaBay Pharmaceuticals

1.38
+0.220018.97%
Post-market: 1.380.0002+0.01%17:38 EDT
Volume:1.06M
Turnover:1.46M
Market Cap:36.74M
PE:-0.36
High:1.49
Open:1.19
Low:1.13
Close:1.16
52wk High:99.75
52wk Low:1.11
Shares:26.63M
Float Shares:2.62M
Volume Ratio:0.80
T/O Rate:40.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8043
EPS(LYR):-12.6737
ROE:-516.26%
ROA:-76.11%
PB:-1.58
PE(LYR):-0.11

Loading ...

NovaBay Pharmaceuticals to change name to Stablecoin Development Corporation

TIPRANKS
·
Yesterday

Press Release: NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update

Dow Jones
·
Yesterday

NovaBay FY 2025 net loss widens to USD 22.14 million as continuing-ops loss more than tripled to USD 33.22 million

Reuters
·
Mar 20

NovaBay Pharmaceuticals Announces 1-for-5 Reverse Stock Split

Reuters
·
Feb 12

NovaBay Pharmaceuticals Inc. Announces Date for Upcoming Special Meeting of Stockholders

Reuters
·
Jan 31

Amex Halt Add Info Lst 2.110000

THOMSON REUTERS
·
Jan 28

Small U.S. Stocks Decrease; NovaBay Pharmaceuticals Posts Biggest Loss

Dow Jones
·
Jan 21

Top Midday Decliners

MT Newswires Live
·
Jan 21

NovaBay Pharmaceuticals Reports At-The-Market Equity Program

MT Newswires Live
·
Jan 21

NovaBay trading halted, volatility trading pause

TIPRANKS
·
Jan 20

Amex Halt Add Info Lst 9.690000

THOMSON REUTERS
·
Jan 20

NovaBay Pharmaceuticals Inc - Files for Offering of up to $100 Mln Common Stock - SEC Filing

THOMSON REUTERS
·
Jan 20

Assessing NovaBay Pharmaceuticals (NBY) Valuation After Digital Asset Financing And SKY Token Treasury Shift

Simply Wall St.
·
Jan 19

NovaBay falls -17.1%

TIPRANKS
·
Jan 13

Amex Halt Add Info Lst 10.690000

THOMSON REUTERS
·
Jan 13

Small U.S. Stocks Move Upward; NovaBay Pharmaceuticals Climbs Highest

Dow Jones
·
Jan 10

NovaBay Pharmaceuticals Reports Turnaround in Earnings

TIPRANKS
·
Nov 14, 2025

NovaBay Pharmaceuticals Inc. Files Initial Beneficial Ownership Statement for CEO and Director Michael Kazley

Reuters
·
Oct 21, 2025

NovaBay Pharmaceuticals, Inc. Regains Compliance With Nyse American Continued Listing Standards

THOMSON REUTERS
·
Oct 21, 2025

NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards

GlobeNewswire
·
Oct 21, 2025